Roberto Pola Selected Research

4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acid

1/2021

Pulmonary Embolism in COVID-19 Patients: Which Diagnostic Algorithm Should We Use?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto Pola Research Topics

Disease

7	Neoplasms (Cancer) 10/2023 - 12/2013
6	Venous Thromboembolism 10/2023 - 08/2012
6	Hemorrhage 01/2023 - 12/2002
6	Ischemia 12/2013 - 07/2003
6	Inflammation (Inflammations) 02/2013 - 09/2002
6	Alzheimer Disease (Alzheimer's Disease) 10/2006 - 09/2002
5	COVID-19 10/2021 - 01/2020
5	Stroke (Strokes) 06/2020 - 04/2003
4	Thrombosis (Thrombus) 01/2024 - 08/2012
3	Venous Thrombosis (Deep-Vein Thrombosis) 04/2024 - 01/2020
3	Hereditary Hemorrhagic Telangiectasia 05/2022 - 12/2019
3	Ischemic Stroke 08/2012 - 04/2003
3	Myocardial Ischemia (Ischemic Heart Diseases) 04/2011 - 06/2003
3	Amyloid Plaque 01/2004 - 01/2003
2	Rhabdomyolysis 01/2023 - 01/2021
2	Muscular Diseases (Myopathy) 01/2023 - 01/2021
2	Myalgia 01/2023 - 01/2021
2	Fibrosis (Cirrhosis) 10/2022 - 03/2014
2	Upper Extremity Deep Vein Thrombosis 01/2022 - 08/2020
2	Pulmonary Embolism 01/2022 - 06/2020
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 01/2020
2	Arteriovenous Malformations (Arteriovenous Malformation) 12/2018 - 02/2013
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2014 - 08/2012
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2014 - 07/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 08/2012
2	Type 2 Diabetes Mellitus (MODY) 08/2010 - 05/2008
2	Dementia (Dementias) 10/2006 - 01/2004
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 10/2006 - 07/2002
2	Crohn Disease (Crohn's Disease) 06/2006 - 04/2005
2	Ulcerative Colitis 06/2006 - 04/2005
2	Brain Ischemia (Cerebral Ischemia) 04/2003 - 07/2002
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2002 - 07/2002
1	Body Weight (Weight, Body) 01/2024
1	Endotoxemia 12/2023
1	Dysbiosis 12/2023
1	Hepatocellular Carcinoma (Hepatoma) 10/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Scurvy (Scorbutus) 10/2021
1	Epistaxis (Nosebleed) 05/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Myocardial Infarction 06/2020
1	Retinal Artery Occlusion 06/2020
1	Atrial Fibrillation 06/2020
1	Glioma (Gliomas) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2019
1	Telangiectasis (Telangiectasia) 12/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2018
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2013
1	Non-ST Elevated Myocardial Infarction 10/2013
1	Disease Susceptibility (Diathesis) 02/2013
1	Necrosis 02/2013
1	Peripheral Arterial Disease 08/2012

Drug/Important Bio-Agent (IBA)

7	AnticoagulantsIBA 01/2023 - 09/2016
5	Proteins (Proteins, Gene)FDA Link 12/2013 - 07/2003
5	Interleukin-6 (Interleukin 6)IBA 02/2013 - 07/2002
4	Oxygen (Dioxygen)IBA 01/2020 - 04/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2005 - 11/2003
4	CytokinesIBA 11/2004 - 09/2002
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2004 - 07/2002
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 01/2021
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2013 - 04/2011
2	RivaroxabanIBA 01/2024 - 10/2023
2	edoxabanIBA 01/2024 - 01/2022
2	Heparin (Liquaemin)FDA LinkGeneric 01/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 05/2017 - 08/2004
2	Genetic Markers (Genetic Marker)IBA 01/2014 - 10/2006
1	apixabanIBA 01/2024
1	Factor Xa InhibitorsIBA 01/2024
1	trimethyloxamine (trimethylamine N-oxide)IBA 12/2023
1	LipopolysaccharidesIBA 12/2023
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2023
1	FatsIBA 10/2022
1	EndoglinIBA 05/2022
1	activin AIBA 05/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	Fondaparinux (Arixtra)FDA Link 01/2022
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2021
1	fibrin fragment D (D-dimer)IBA 10/2021
1	IronIBA 05/2021
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 01/2021
1	cupric sulfide (CuS)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 10/2018
1	DystrophinIBA 12/2013
1	matrigelIBA 12/2013
1	Troponin T (Troponin T1)IBA 10/2013
1	IntegrinsIBA 02/2013
1	Activins (Activin)IBA 02/2013
1	Fibronectins (Fibronectin)IBA 02/2013
1	Phosphotransferases (Kinase)IBA 02/2013

Therapy/Procedure

8	Therapeutics 01/2023 - 01/2012
2	Secondary Prevention 10/2023 - 06/2020
2	Central Venous Catheters 01/2022 - 08/2020
1	Vena Cava Filters (Inferior Vena Cava Filter) 04/2024
1	Contraindications 04/2024
1	Indwelling Catheters (Indwelling Catheter) 01/2022
1	Catheters 01/2022
1	Blood Transfusion (Blood Transfusions) 05/2021
1	Length of Stay 01/2021
1	Noninvasive Ventilation 01/2020